BRIEF REVIEW ON MULTIPLE SCLEROSIS

Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 11

Abstract

There is no known cure for multiple sclerosis. Treatments attempt to improve function after an attack and prevent new attacks. Medications used to treat MS, while modestly effective, can have side effects and be poorly tolerated Multiple sclerosis usually starts with an acute episode of neurological disturbance, termed a 'clinically isolated syndrome', followed by an illness phase punctuated by relapses and remissions which may transition after 10 years to a phase of progressive accumulation of disability without relapses. Fifteen to 20% of patients will have a progressive course from the onset. There is significant interpatient variability in prognosis. The main diagnostic criteria are clinical, supported by investigations including magnetic resonance imaging and lumbar puncture and evoked potentials. First line disease modifying agents for relapsing remitting multiple sclerosis include interferon-ß and glatiramer. First line treatment for relapses is usually intravenous methylprednisolone for 3 days. Troublesome symptoms may include spasticity, parasthesias, tremor, erectile dysfunction, depression and anxiety, fatigue and pain. After excluding differential diagnoses, symptomatic management includes pharmacological agents, allied health consultation and continence strategies. Although pregnancy reduces disease activity, there is a higher risk of relapse in the postpartum period.

Authors and Affiliations

Deepak Bhatt

Keywords

.

Related Articles

ROLE OF FREE RADICALS IN PHYSIOLOGY AND PATHOLOGY

Free radicals having unpaired electrons in their outer shell are potent oxidizing or reducing agents against any molecule they happen to contact, making them very toxic in biological systems. ROS such as superoxide radic...

AWARENESS OF PARENTS TOWARD OTITIS MEDIA IN MAJMAAH CITY, SAUDI ARABIA, 2018

Otitis media (OM) and its complications resulted in high prevalence of hearing loss and increasing the rates of health care visits with special regard to the developing countries. The prevalence of AOM in the children fr...

STUDY ON DIGESTIVE PHYSIOLOGY OF RUMEN IN SELECTED CATTLE SLAUGHTERED AT ADDIS ABABA ABATTOIR, ETHIOPIA

A cross sectional study was conducted from November 2009 to April 2010 on 210 cattle in Addis-Ababa abattoir, originating from every corner of the country including Addis Ababa for the aim of quantifying functional rumen...

LOCAL SURVEY FOR AWARENESS OF HYPERACIDITY AND/OR OTHER ASSOCIATED PROBLEMS

Awareness for Hyperacidity and associated problems was judged in a population of Worli area of Mumbai during a medical camp held on March 15, 2017 at the campus of M.A. Podar (Govt.) Hospital, Worli, Mumbai-18. As prepar...

THE EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY ASSOCIATED WITH MUTATION IN GABRB3 GENE

GABRB3 gene, located on chromosome 15q11.2-q12, encodes β3- subunit of the GABAA receptor. The reduced GABRB3 expression underlies in the pathogenesis of absence seizures, abnormal sensory processing, and other neurodeve...

Download PDF file
  • EP ID EP618243
  • DOI -
  • Views 179
  • Downloads 0

How To Cite

Deepak Bhatt (2017). BRIEF REVIEW ON MULTIPLE SCLEROSIS. World Journal of Pharmaceutical Research, 6(11), 180-194. https://europub.co.uk/articles/-A-618243